Targeting the KDM4B–AR–c‐Myc axis promotes sensitivity to androgen receptor‐targeted therapy in advanced prostate cancer-Reference-Cited by-全球学者库

Targeting the KDM4B–AR–c‐Myc axis promotes sensitivity to androgen receptor‐targeted therapy in advanced prostate cancer

Published:2020-08-28 Issue:2 Volume:252 Page:101-113
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Tang Dong‐E¹,Dai Yong¹,He Jia‐Xi²,Lin Lie‐Wen¹,Leng Qi‐Xin²,Geng Xin‐Yan³,Fu De‐Xue⁴,Jiang Hao‐Wu⁵,Xu Song‐Hui¹²^ORCID

Affiliation:

1. Department of Clinical Medical Research Center The Second Clinical Medical College of Jinan University, The First Affiliated Hospital Southern University of Science and Technology, Shenzhen People's Hospital Shenzhen PR China

2. Department of Pathology, Marlene and Stewart Greenebaum Cancer Center University of Maryland School of Medicine Baltimore MD USA

3. Department of Biochemistry, Marlene and Stewart Greenebaum Cancer Center University of Maryland School of Medicine Baltimore MD USA

4. Department of Surgery, Marlene and Stewart Greenebaum Cancer Center University of Maryland School of Medicine Baltimore MD USA

5. Department of Anesthesiology and Center for the Study of Itch Washington University School of Medicine St Louis MO USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5495

Reference47 articles.

1. Cancer statistics, 2012

2. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion

3. Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer

4. Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer

5. KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The emerging roles of histone demethylases in cancers;Cancer and Metastasis Reviews;2024-01-16

2. Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability;Clinical Epigenetics;2023-12-13

3. Androgen Receptor–Interacting Proteins in Prostate Cancer Development and Therapy Resistance;The American Journal of Pathology;2023-12

4. Retraction Note: Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer;Cancer Gene Therapy;2023-09-21

5. KDM4B down-regulates ERα signaling independent on its demethylase activity in vascular calcification;2023-06-28